The new “2024 China Ophthalmic Market Report” features expanded analysis of regulations and a snapshot of the Chinese government’s Volume-Based Procurement strategies designed to reduce prices and improve access to care. All product category forecasts have been updated through 2029 and examine revenue in both yuan and dollars.
The new report provides updates on Chinese companies and private hospital chains, thoroughly examines ophthalmic product candidates at Chinese pharmaceutical companies, and provides an updated listing of companies selling and distributing ophthalmic products in China.
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.